Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?
about
Quality of Life in Glaucoma: A Review of the LiteratureCombination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focusAdvantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol CombinationSystematic Review of Educational Interventions to Improve Glaucoma Medication Adherence: an update in 2015Persistency rates for prostaglandin and other hypotensive eyedrops: population-based study using pharmacy claims data.Considerations in glaucoma therapy: fixed combinations versus their component medications.Glaucoma patients' trust in the physicianAdjunctive therapy patterns in glaucoma patients using prostaglandin analogs.Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational studyFirst-year treatment costs among new initiators of topical prostaglandin analogs: pooled results.Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs.Identification of noncompliant glaucoma patients using Bayesian networks and the Eye-Drop Satisfaction Questionnaire.Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic reviewThe relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.iStent with Phacoemulsification versus Phacoemulsification Alone for Patients with Glaucoma and Cataract: A Meta-Analysis.Analysis of Factors Affecting Patients' Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model.A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma.Selective Laser Trabeculoplasty: A Clinical Review.Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs.Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic MonitorsApplying the resources and supports in self-management framework to examine ophthalmologist-patient communication and glaucoma medication adherence.Failure of medical therapy despite normal intraocular pressure.Developments in dosing aids and adherence devices for glaucoma therapy: current and future perspectives.Fixed-combination and emerging glaucoma therapies.The influence of health literacy level on an educational intervention to improve glaucoma medication adherence.Co-prescribing of topical and systemic beta-blockers in patients with glaucoma: a quality use of medicine issue in Australian practice.Travoprost/timolol fixed combination.Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence.Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study.Validation of a glaucoma knowledge assessment in glaucoma patients.First-year treatment costs among new initiators of topical prostaglandin analogs.Perspectives on Quality of Life in Glaucoma.Diurnal intraocular pressure with bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in healthy subjects.Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.Provider use of collaborative goal setting with glaucoma patients.Travoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical review.Intraocular pressure-lowering combination therapies with prostaglandin analogues.Latanoprost/timolol fixed combination for the treatment of glaucoma.Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice.Brinzolamide plus brimonidine for the treatment of glaucoma: an update.
P2860
Q26747891-DC7D43EA-EFE1-4D0A-A6E7-7D100A2174B3Q26830201-72F6A1E8-773C-4A25-B16D-A37FE6902334Q28552385-5026D1B5-398B-4450-A44B-495722542995Q30749049-7EC10325-1673-4025-8F32-9F166869F14DQ31130996-21AE7409-85E4-48BE-988D-B01762FED9EEQ33644139-860C47DD-02D9-4717-A233-84C464918D74Q33720403-65F5CBC6-E71C-478E-93CA-CBBFCFDA00F9Q33769480-5994C1E4-F143-43B1-A89D-B2FF987AF3D6Q33803702-D9A7D9F4-A894-4796-BC0B-1633D1D98CE9Q33867907-232AC37A-6279-4EBA-A932-F892274EFF67Q34188280-9638EF7B-5F21-4933-8E85-9906AD8D3C43Q34439372-05C65437-4212-4534-BB0D-A5028DD6C0F3Q35327935-5688E5EE-C842-4C66-9EF6-F13C8CE9911BQ35571666-412CB219-748E-4CD5-B3CC-F5C230397FE0Q35683969-668B5FF9-1397-40B5-BBFD-36ACE0998CEDQ35807582-7CFA24E3-776C-48D8-BF0C-F720D6225CBAQ35906365-239DAFC9-D9BC-452E-920F-18BF982B249EQ35964395-2DD0C6B1-73CC-4DC4-992F-DFEAF1796DD5Q35995429-7341BE15-A7C6-4373-A3AC-607EB8A0CF7CQ36055050-16FFDF05-CFA4-4E91-A1B0-80DA3D6A4873Q36344429-6812C171-CB5C-4DA5-9C4C-EC7018619BBBQ36689212-2C8B1754-8045-44E7-BFB0-BB698868F0D8Q36759536-34E3B9E2-0681-42E3-B83C-19122D276909Q36866626-86DB9FAE-089E-498D-9A76-5B3010CE2347Q36990641-6F9E2C56-34B2-4EEC-92BE-D091108B83B0Q36998907-082DCB3C-DBC0-4BDE-84AA-44371F16258EQ37123433-41740726-2A9E-4120-A714-4E8834BCBEC1Q37196711-DD7F9A39-5FC3-4A8D-8874-B0500D3A53D9Q37250462-98B9DE85-5E3A-404F-A759-178F6042F84BQ37337958-DD8C39D5-4C5B-43C4-A5FA-94F42100D25BQ37458863-9DA23BA7-DC1F-479B-AED1-17EACC13E2AAQ37507384-7143AD76-C5F0-4D3E-B422-6596D7962F5CQ37555451-2614387A-DD02-462A-8CE6-24223F9B75A4Q37716010-426C107D-2A99-44A8-B5B9-FA9D9A0C6F75Q37733699-411E6BA8-8AF4-427B-A806-32D6BCC0F7ADQ37831356-C64B0650-2B84-43D5-AC4D-5C54E91F8381Q38017728-2DCE281B-EB40-4ADA-9721-D32169A1E4FCQ38117401-B00FE0CA-2146-4776-AFE1-4706E63FE937Q38226662-33F8F1F3-A711-405E-A119-36F09FDA2DBCQ38255431-49E3EA47-1772-4C8D-A23D-BDF12440F68A
P2860
Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?
@ast
Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?
@en
type
label
Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?
@ast
Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?
@en
prefLabel
Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?
@ast
Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?
@en
P1433
P1476
Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?
@en
P2093
David Covert
P304
P356
10.1016/J.OPHTHA.2004.12.026
P577
2005-05-01T00:00:00Z